Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacology of Dopamine and Its Receptors
Sunpreet Kaur, Shamsher Singh, Gagandeep Jaiswal, et al.
Springer eBooks (2020), pp. 143-182
Closed Access | Times Cited: 14

Showing 14 citing articles:

Dopamine in Parkinson's disease
Saad Latif, Muhammad Jahangeer, Dure Maknoon Razia, et al.
Clinica Chimica Acta (2021) Vol. 522, pp. 114-126
Closed Access | Times Cited: 222
Diabetes and Cognitive Impairment: A Role for Glucotoxicity and Dopaminergic Dysfunction
Francesca Chiara Pignalosa, Antonella Desiderio, Paola Mirra, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12366-12366
Open Access | Times Cited: 75
In situ growth of BiVO4–Bi2O3 p-n heterojunction nanocomposite via facile green combustion method: Efficient photocatalytic activity under visible light, photoluminescence and biosensing applications
E. Vinay kumar, T. L. Soundarya, Anitha, et al.
Materials Chemistry and Physics (2024) Vol. 317, pp. 129187-129187
Closed Access | Times Cited: 13
Exosome: an overview on enhanced biogenesis by small molecules
Amir Bavafa, Maryam Izadpanahi, Elham Hosseini, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Postbiotics as a Therapeutic Tool in Alzheimer's Disease: Insights into Molecular Pathways and Neuroprotective Effects
Garry Hunjan, Khadga Raj Aran
Ageing Research Reviews (2025), pp. 102685-102685
Closed Access
The Impact of Microbiota on Neurological Disorders: Mechanisms and Therapeutic Implications
Giuseppe Merra, Giada La Placa, Marcello Covino, et al.
OBM Neurobiology (2025) Vol. 09, Iss. 01, pp. 1-12
Open Access
OLFACTORY DYSFUNCTION: AN EARLY INDICATOR OF PARKINSON'S DISEASE
Dhuly Chowdhury, Ashmita Das, Mrityunjay Mishra, et al.
Brain Disorders (2025), pp. 100209-100209
Open Access
Neuroprotective role of apocynin against pentylenetetrazole kindling epilepsy and associated comorbidities in mice by suppression of ROS/RNS
Gagandeep Jaiswal, Puneet Kumar
Behavioural Brain Research (2021) Vol. 419, pp. 113699-113699
Closed Access | Times Cited: 26
Assessment of the relationship between the dopaminergic pathway and severe acute respiratory syndrome coronavirus 2 infection, with related neuropathological features, and potential therapeutic approaches in COVID‐19 infection
Yousef Rasmi, Ameneh Shokati, Shima Hatamkhani, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 1
Closed Access | Times Cited: 2
Shaping the future of medicine through diverse therapeutic applications of tetralin derivatives
Bhumi Shah, Radhika Kachhadiya
Medicinal Chemistry Research (2024)
Closed Access | Times Cited: 1
The Role of Dopamine Receptor Dimer Complexes in the Pathogenesis of Depression
А. С. Герасимов, О. В. Смирнова
Journal of Evolutionary Biochemistry and Physiology (2024) Vol. 60, Iss. 5, pp. 1960-1974
Closed Access
The role of dopamine receptor dimer complexes in the pathogenesis of depression
А. С. Герасимов, О. V. Smirnova
Российский физиологический журнал им  И  М  Сеченова (2024) Vol. 110, Iss. 10, pp. 1541-1558
Closed Access
Recovery from (treatment-resistant) depression after lifestyle changes and micronutrient precision supplementation: a preliminary field study in patients
Isabella Mader
BMC Psychology (2023) Vol. 11, Iss. 1
Open Access
New Enzymatic Targets for Organophosphorus Compounds

Journal of NBC Protection Corps (2022) Vol. 6, Iss. 4, pp. 342-354
Open Access
Page 1

Scroll to top